Neuroprotective Effects of Long-term TaVNS in Early Parkinson's Disease Patients
RecruitingNCT06665113Phase: NAStarted 2024-12-23
Summary
This study is a randomized, double-blind, controlled trial exploring the effects of long-term taVNS intervention in patients with early-stage Parkinson's disease.
Eligibility
Sex
ALL
Min Age
55 Years
Max Age
75 Years
Locations
The First Affiliated Hospital with Nanjing Medical UniversitNanjing, Jiangsu, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06665113